Liquid Biopsy in HCC: Valuable Tool for Detection, Monitoring
Further research is needed, though, to overcome barriers to the routine clinical use of liquid biopsy for patients with hepatocellular carcinoma (HCC). Medscape Medical News
Immunotherapy Treatment Shows Promise for Resectable Liver Cancer
Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial. Medscape Medical News
Drug Combo Ups Ulcer Risk After Cryoablation in Patients With HCC
Patients with hepatocellular carcinoma should be switched from a PD-1, TKI combination to monotherapy after cryoablation. The study was published as a preprint and has not yet been peer reviewed. First Look
New Guidelines Clarify Use of Systemic Therapy in Advanced HCC
The American Gastroenterological Association published recommendations to help guide the management of hepatocellular carcinoma in the first- and second-line settings. Medscape Medical News
HCC Prevention Should Target Patients With Moderate Fibrosis
Efforts to prevent hepatocellular carcinoma unrelated to hepatitis or cirrhosis should be focused on individuals with an intermediate degree of liver fibrosis, suggests a large-scale data analysis. First Look
Liver Cancer Risk Lingers Even After HCV Eradication
Risk for hepatocellular carcinoma (HCC) is lower for patients who have sustained viral responses after drug therapy for hepatitis C, but this treatment does not cure fibrosis, a common cause of HCC. Medscape Medical News
Tislelizumab Benefit in HCC Undimmed by Prior Therapies
Patients with advanced hepatocellular carcinoma (HCC) can achieve durable responses, and overall survival is "encouraging" with the novel immunotherapy, even after multiple prior therapies. Medscape Medical News
Antibiotics May Prolong PFS in HCC Patients on Immunotherapy
Taking antibiotics 30 days before or after starting an immune checkpoint inhibitor was associated with a benefit in progression-free survival (PFS) for patients with hepatocellular carcinoma. Medscape Medical News
New Combo Shows Benefit Even in Patients With High-Risk HCC
Updated data from the IMBRave150 trial show benefit for the combination of atezolizumab with bevacizumab even in patients with high-risk hepatocellular carcinoma. Medscape Medical News
ASCO Announces New Advanced Liver Cancer Guidelines
New guidelines from the American Society of Clinical Oncology were released to address the treatment of advanced hepatocellular carcinoma. Medscape Medical News
